[HTML][HTML] RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
…, U Kilik, J Langstein, JA Wierzbinska… - Nature …, 2017 - nature.com
Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative disorder of
early childhood characterized by mutations activating RAS signaling. Established clinical and …
early childhood characterized by mutations activating RAS signaling. Established clinical and …
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact
L Mansouri, JA Wierzbinska, C Plass… - Seminars in cancer …, 2018 - Elsevier
Deregulated transcriptional control caused by aberrant DNA methylation and/or histone
modifications is a hallmark of cancer cells. In chronic lymphocytic leukemia (CLL), the most …
modifications is a hallmark of cancer cells. In chronic lymphocytic leukemia (CLL), the most …
Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia
A-kinase anchor protein 12 (AKAP12) is a regulator of protein kinase A and protein kinase
C signaling, acting downstream of RAS. Epigenetic silencing of AKAP12 has been …
C signaling, acting downstream of RAS. Epigenetic silencing of AKAP12 has been …
[HTML][HTML] Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking
…, M Hakobyan, A Touzart, A Goyal, JA Wierzbinska… - Leukemia, 2023 - nature.com
Recurrent translocations are common in acute myeloid leukemia (AML) and important for
cytogenetic classification and prognosis [1]. AML-derived leukemic cell lines have been …
cytogenetic classification and prognosis [1]. AML-derived leukemic cell lines have been …
[HTML][HTML] Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
Background In cancer, normal epigenetic patterns are disturbed and contribute to gene
expression changes, disease onset, and progression. The cancer epigenome is composed of the …
expression changes, disease onset, and progression. The cancer epigenome is composed of the …
Bioactive forms of vitamin D selectively stimulate the skin analog of the hypothalamus-pituitary-adrenal axis in human epidermal keratinocytes
JM Wierzbicka, MA Żmijewski, A Piotrowska… - Molecular and cellular …, 2016 - Elsevier
Ultraviolet radiation B stimulates both the production of vitamin D 3 in the skin and the activation
of the skin analog of the hypothalamic-pituitary-adrenal axis (HPA) as well as the central …
of the skin analog of the hypothalamic-pituitary-adrenal axis (HPA) as well as the central …
[HTML][HTML] The effects of vitamin D on the expression of IL-33 and its receptor ST2 in skin cells; potential implication for psoriasis
JM Wierzbicka, A Piotrowska… - International Journal of …, 2021 - mdpi.com
Interleukin 33 (IL-33) belongs to the IL-1 family and is produced constitutively by epithelial
and endothelial cells of various organs, such as the skin. It takes part in the maintenance of …
and endothelial cells of various organs, such as the skin. It takes part in the maintenance of …
[HTML][HTML] Vitamin D enhances anticancer properties of cediranib, a VEGFR inhibitor, by modulation of VEGFR2 expression in melanoma cells
A Piotrowska, FP Beserra, JM Wierzbicka… - Frontiers in …, 2021 - frontiersin.org
Regardless of the recent groundbreaking introduction of personalized therapy, melanoma
continues to be one of the most lethal skin malignancies. Still, a substantial proportion of …
continues to be one of the most lethal skin malignancies. Still, a substantial proportion of …
Differentiation of keratinocytes modulates skin HPA analog
JM Wierzbicka, MA Żmijewski… - Journal of Cellular …, 2017 - Wiley Online Library
It is well established, that epidermal keratinocytes express functional equivalent of
hypothalamus–pituitary–adrenal axis (HPA) in order to respond to changing environment and …
hypothalamus–pituitary–adrenal axis (HPA) in order to respond to changing environment and …
[HTML][HTML] VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells
JI Nowak, AM Olszewska, JM Wierzbicka, M Gebert… - Cells, 2023 - mdpi.com
The genomic activity of 1,25(OH) 2 D 3 is mediated by vitamin D receptor (VDR), whilst non-genomic
is associated with protein disulfide isomerase family A member 3 (PDIA3). …
is associated with protein disulfide isomerase family A member 3 (PDIA3). …